Antibody Drug Conjugate Market

LAS VEGAS, NV, UNITED STATES, January 23, 2025 /EINPresswire.com/ -- The Global Antibody Drug Conjugate Market was valued at USD 10.13 billion in 2023, growing at a CAGR of 14.37% during the forecast period from 2024 to 2030 to reach USD 25.79 billion by 2030. The demand for antibody-drug conjugates is primarily being boosted by the growing prevalence of cancer globally, increasing research & development activities, and clinical trials for the development of antibody-drug conjugates, during the forecast period from 2024-2030.

Key Takeaways from the Antibody Drug Conjugate Market Report
• In January 2025:- Sutro Biopharma Inc.- A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody-Drug Conjugate (ADC), in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers.
• As per DelveInsight estimates, North America is anticipated to dominate the Global Antibody Drug Conjugate Market during the forecast period.
• The leading Antibody Drug Conjugate Companies such as F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED, Pfizer Inc., Gilead Sciences, Inc., ADC Therapeutics SA., GSK plc, Mersana Therapeutics., Astellas Pharma Inc., AstraZeneca, ImmunoGen Inc. and others.

To read more about the latest highlights related to the Antibody Drug Conjugate Market, get a snapshot of the key highlights entailed in the Global Antibody Drug Conjugate Market Report

Antibody Drug Conjugate Overview
Antibody Drug Conjugates (ADCs) are emerging as a groundbreaking innovation in the field of oncology, transforming the way we perceive and treat cancer. By combining the specificity of monoclonal antibodies with the potency of cytotoxic drugs, ADCs offer a precision medicine approach that delivers therapeutic agents directly to cancer cells while sparing healthy tissues.

Antibody Drug Conjugate Market Dynamics
According to the International Agency for Research on Cancer (IARC) report 2022, there were almost 20 million new cases of cancer and close to 10 million deaths from cancer in 2022. Demographics-based predictions indicated that the annual number of new cases of cancer will reach 35 million by 2050, that is, a 77% increase from the number in 2022. The increasing number of people affected with cancer is expected to drive the demand for antibody-drug conjugates in the forecasted period, thus resulting in the positive growth of the antibody-drug conjugate market.

To know more about why North America is leading the market growth in the Antibody Drug Conjugate Market, get a snapshot of the Global Antibody Drug Conjugate Market Outlook

Antibody Drug Conjugate Companies
F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED, Pfizer Inc., Gilead Sciences, Inc., ADC Therapeutics SA., GSK plc, Mersana Therapeutics., Astellas Pharma Inc., AstraZeneca, ImmunoGen Inc. and others.

Antibody Drug Conjugate Market Segment Analysis
Antibody Drug Conjugate Market by Cancer Type (Breast Cancer, Lung Cancer, Bladder Cancer, Brain Tumor, and Others), Target Type (CD19, HER2, CD22, and Others), End-User (Hospitals and Specialty Cancer Centers, Biotechnology and Pharmaceutical Companies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). In the cancer type segment of the antibody drug conjugate market, the breast cancer category is estimated to amass a significant revenue share in the antibody drug conjugate market in 2023. This can be attributed to the large patient population associated with breast cancer and the rising product development activities and availability of drugs related to breast cancer.

Antibody Drug Conjugate Market Drivers
The Antibody Drug Conjugate Market is slated to witness prosperity owing to the growing prevalence of cancer globally, increasing research & development activities, and clinical trials for the development of antibody-drug conjugates, during the forecast period from 2024-2030.

Get a sneak peek at the Antibody Drug Conjugate Market Dynamics @ Antibody Drug Conjugate Market Dynamics Analysis

Scope of the Antibody Drug Conjugate Market Report
• Coverage- Global
• Antibody Drug Conjugate Companies- F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED, Pfizer Inc., Gilead Sciences, Inc., ADC Therapeutics SA., GSK plc, Mersana Therapeutics., Astellas Pharma Inc., AstraZeneca, ImmunoGen Inc. and others.
• Antibody Drug Conjugate Market Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
• Antibody Drug Conjugate Competitive Landscape, Regulatory Analysis, Key Factor Analysis, Market Assessment

Which MedTech key players in the Antibody Drug Conjugate Market are set to emerge as the trendsetter explore @ Antibody Drug Conjugate Companies- https://www.delveinsight.com/sample-request/antibody-drug-conjugate-adc-market?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Antibody Drug Conjugate Market Report Introduction
2. Antibody Drug Conjugate Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Antibody Drug Conjugate Market Key Factors Analysis
6. Antibody Drug Conjugate Market Porter’s Five Forces Analysis
7. Antibody Drug Conjugate Market Assessment
8. Antibody Drug Conjugate Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Interested in knowing the Antibody Drug Conjugate Market by 2030? Click to get a snapshot of the Antibody Drug Conjugate Market Trends- https://www.delveinsight.com/sample-request/antibody-drug-conjugate-adc-market?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=ypr

List of Top Selling Market Research Reports in 2025

Varicose Vein Treatment Devices Market - https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Vascular Access Devices Market - https://www.delveinsight.com/report-store/vascular-access-device-market
Indwelling Catheters Market - https://www.delveinsight.com/report-store/indwelling-catheters-market
Healthcare Competitive Benchmarking - https://www.delveinsight.com/consulting/competitive-benchmarking-services
Lymphoedema Market - https://www.delveinsight.com/report-store/lymphoedema-market
Pacemakers Market - https://www.delveinsight.com/report-store/pacemakers-market
Myeloproliferative Neoplasms Market - https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
Surgical Mask & Respirator Market - https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Nk Cell Therapy Market - https://www.delveinsight.com/report-store/nk-cell-therapy-market
Novel Drug Delivery Devices Market - https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Testicular Neoplasm Market - https://www.delveinsight.com/report-store/testicular-cancer-pipeline-insight
Phototherapies For Psoriasis Market - https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Skin Neoplasm Market - https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market
Microscopy Device Market - https://www.delveinsight.com/report-store/microscopy-device-market
Bone Growth Stimulator Market - https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Urea Cycle Disorders Market - https://www.delveinsight.com/report-store/urea-cycle-disorders-market
Antibody Drug Conjugate Market - https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Cardiac Implantable Electronic Devices Market - https://www.delveinsight.com/report-store/cardiac-implantable-electronic-devices-cieds-market
Dyspepsia Market - https://www.delveinsight.com/report-store/functional-dyspepsia-epidemiology-forecast-insight
Lactose Intolerance Market - https://www.delveinsight.com/report-store/lactose-intolerance-market
Medical Marijuana Market - https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Asperger Syndrome Market - https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Catheter Stabilization Devices Market - https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market

Yash Bhardwaj
DelveInsight
+91 9650213330
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.